A
AMYLYX PHARMACEUTICALS INC
NASDAQ: AMLX (Amylyx Pharmaceuticals, Inc.)
Kemas kini terakhir: semalam, 6:40PM28.86
0.18 (0.63%)
| Penutupan Terdahulu | 28.68 |
| Jumlah Dagangan | 989,514 |
| Harga / Buku (P/B) | 13.35 |
| Julat 52 Minggu |
| Margin Operasi (TTM) | 16,317.06% |
| EPS Cair (TTM) | -3.10 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -99.60% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 0.69% |
| Nisbah Semasa (MRQ) | 12.05 |
| Aliran Tunai Operasi (OCF TTM) | -206.98 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -182.62 M |
| Pulangan Atas Aset (ROA TTM) | -40.72% |
| Pulangan Atas Ekuiti (ROE TTM) | -83.24% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Drug Manufacturers - Specialty & Generic (US) | Bercampur | Bercampur |
| Drug Manufacturers - Specialty & Generic (Global) | Bercampur | Bercampur | |
| Stok | Amylyx Pharmaceuticals, Inc. | Bercampur | Menaik |
AISkor Stockmoo
| Konsensus Penganalisis | 0.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -1.6 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | -2.0 |
| Penilaian Relatif | NA |
| Kesihatan Kewangan | 0.0 |
| Persekitaran Makro | -0.3 |
| AI Insight | NA |
| AI Technical | NA |
| Purata | -0.70 |
|
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder and endocrine conditions. |
|
| Sektor | Healthcare |
| Industri | Drug Manufacturers - Specialty & Generic |
| Gaya Pelaburan | Small Growth |
| % Dimiliki oleh Orang Dalam | 9.54% |
| % Dimiliki oleh Institusi | 85.89% |
Tiada data dalam julat masa ini.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |